MondayNov 03, 2008 6:11 am

The Female Health Company (AMEX: FHC)

The Female Health Company (AMEX: FHC), the sole manufacturer and marketer of the FC1 and FC2 female condoms, provides an innovative option to women that protects against both sexually transmitted diseases and unintended pregnancy. The Company holds exclusive product and technology patents for FC1 in the United States, Australia, Brazil, Canada, France, Germany, Italy, Spain, the United Kingdom, the People’s Republic of China, South Korea and Japan, while patents are pending for FC2. For further information, visit the Company's web site at www.femalehealth.com.

Continue Reading

MondayNov 03, 2008 6:10 am

Ternium S.A. (NYSE: TX)

Ternium S.A. (NYSE: TX), a manufacturer of flat and long steel products, is focused on consolidating the operations of steel companies located in Argentina, Mexico, Guatemala and United States. Ternium is one of Latin America’s leading steel companies with an annual crude steel production capacity of 10.8 million tons. Under the direction of Chairman Paolo Rocca, and CEO Daniel Novegil, Ternium brings the professionalism and dedication of more than 18,000 employees. For further information, visit the Company's web site at http://www.ternium.com/en.

Continue Reading

MondayNov 03, 2008 6:10 am

TechPrecision Corporation (OTC BB: TPCS)

TechPrecision Corporation (OTC BB: TPCS) is focused on excelling in the precision manufacturing industry while offering comprehensive program management and integration services. The company’s customer base resides within a broad range of industries, including Aerospace, Alternative Energy, Medical and Nuclear industry segments. Chairman and CEO James Reindl leads the company with more than 15 years experience in the management of multi-company operations. For further information, visit the Company's web site www.techprecision.com.

Continue Reading

MondayNov 03, 2008 6:09 am

Targeted Genetics Corporation (NASDAQ: TGEN)

Targeted Genetics Corporation (NASDAQ: TGEN) is focused on developing and commercializing molecular therapeutics that target the underlying cause of an array of serious diseases that have substantial, but unmet medical needs. The company’s lead product candidate is being designed to treat inflammatory arthritis, and additional programs target HIV/AIDS, congestive heart failure and Huntington's disease. Targeted Genetics’ varied pipeline has been developed through the leveraging of the company’s intellectual property related to gene delivery, and core capabilities in critical functions. For further information, visit the Company's web site at www.targetedgenetics.com.

Continue Reading

MondayNov 03, 2008 6:03 am

East Asia Minerals Corporation (TSX: EAS CN)

East Asia Minerals Corporation (TSX: EAS CN), a well-financed, Asian-based, Canadian mineral exploration company, is focused on executing its aggressive exploration, acquisition and growth strategy. The company explores advanced gold and gold-copper properties in Indonesia and advanced uranium properties in Mongolia. East Asia currently owns ten uranium properties, including the advanced Ingiin-Nars, Ulaan Nuur and Enger uranium projects, and a 75% interest in the Khok Adar copper oxide discovery in Mongolia. For further information, visit the Company's web site at www.eaminerals.com.

Continue Reading

MondayNov 03, 2008 6:02 am

Dyax Corp. (NASDAQ: DYAX)

Dyax Corp. (NASDAQ: DYAX) is focused on discovering, developing, and commercializing novel biopharmaceuticals for medical needs that are currently unmet. The company hopes to meet its objectives while delivering outstanding value to patients and stockholders. Their produce candidates include fully human monoclonal antibodies in addition to small proteins and peptides. For further information, visit the Company's web site at www.dyax.com.

Continue Reading

MondayNov 03, 2008 6:01 am

DUSA Pharmaceuticals, Inc. (NASDAQ: DUSA)

DUSA Pharmaceuticals, Inc. (NASDAQ: DUSA), an integrated dermatology pharmaceutical company, has its primary focus on developing and marketing its Levulan® Photodynamic Therapy (PDT) technology platform, and complementary dermatology products. Levulan PDT is approved to treat of Grade 1 or 2 actinic keratoses of the face or scalp. ClindaReach is the company’s other dermatology product. Additionally DUSA is researching other indications for Levulan PDT including oral Leukoplakia and the prevention of AKs and SCCs. For further information, visit the Company's web site at www.dusapharma.com.

Continue Reading

MondayNov 03, 2008 6:01 am

Alpharma, Inc. (NYSE: ALO)

Alpharma, Inc. (NYSE: ALO), a global specialty pharmaceutical company, has an expanding branded franchise within the U.S. pain market with its KADIAN Capsules and the FLECTOR Patch 1.3%. The company is active in over 80 countries and is known throughout the world as a leading provider of pharmaceutical products for poultry and livestock. For further information, visit the Company's web site at www.alpharma.com.

Continue Reading

MondayNov 03, 2008 6:00 am

Dune Energy, Inc. (AMEX: DNE)

Dune Energy, Inc. (AMEX: DNE), an independent exploration and development company, has its operations focused along the Louisiana/Texas Gulf Coast. The company currently operates more than 90% of its production and typically maintains a 100% WI. As of January 1, 2008, the company’s proved reserves totaled 175 Bcfe. Dune intends to continue exploiting its existing asset base, while seeking accretive acquisitions and entering into additional joint venture drilling programs. For further information, visit the Company's web site at www.duneenergy.com.

Continue Reading

MondayNov 03, 2008 5:59 am

Duluth Metals Limited (TSX: DM CN)

Duluth Metals Limited (TSX: DM CN), a Canadian Corporation, is dedicated to exploring and developing copper, nickel and platinum group metal (PGM) deposits within the emerging Duluth Complex mining camp in northeastern Minnesota, USA. The company’s asset, Nokomis Deposit, is estimated to contain 449 million tonnes of the higher classification resource category of Indicated Resources grading 0.624% copper, 0.199% nickel, 0.600 grams per tonne of total precious metals (TPM = Platinum+Palladium+Gold), and an additional 284 million tonnes of Inferred Resources grading 0.627% copper, 0.194% nickel, 0.718 grams per tonne of TPM. For further information, visit the Company's web site at…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered